{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:19:37Z","timestamp":1771949977276,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ejso.2006.05.015","type":"journal-article","created":{"date-parts":[[2006,7,12]],"date-time":"2006-07-12T09:34:59Z","timestamp":1152696899000},"page":"964-969","source":"Crossref","is-referenced-by-count":26,"title":["Salvage radical prostatectomy for radiorecurrent prostate cancer: Indications and results"],"prefix":"10.1016","volume":"32","author":[{"given":"J.","family":"Darras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Van Poppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2006.05.015_bib1","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1877::AID-CNCR32>3.0.CO;2-5","article-title":"The National Cancer Data Base report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S","volume":"86","author":"Mettlin","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2006.05.015_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0094-0143(02)00002-2","article-title":"Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database","volume":"29","author":"Stephenson","year":"2002","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ejso.2006.05.015_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.urology.2003.09.001","article-title":"Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer","volume":"62","author":"Chen","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejso.2006.05.015_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0360-3016(95)00137-N","article-title":"Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer","volume":"32","author":"Kuban","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2006.05.015_bib5","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1200\/JCO.2002.03.061","article-title":"Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer","volume":"20","author":"D'Amico","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2006.05.015_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0360-3016(01)02778-X","article-title":"Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era","volume":"52","author":"Kupelian","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2006.05.015_bib7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.281.17.1598","article-title":"Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis","volume":"281","author":"Shipley","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2006.05.015_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1053-4296(03)70010-1","article-title":"Salvage radical prostatectomy: refinement of an effective procedure","volume":"13","author":"Pisters","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ejso.2006.05.015_bib9","first-page":"34","article-title":"Salvage radical prostatectomy","volume":"16","author":"Eastham","year":"2004","journal-title":"Contemp Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1200\/JCO.1997.15.1.230","article-title":"Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations","volume":"15","author":"Lee","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2006.05.015_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8","article-title":"Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer","volume":"74","author":"Pollack","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2006.05.015_bib12","first-page":"1035","article-title":"Consensus Statement: Guidelines for PSA following radiation therapy","volume":"37","author":"American Society for Therapeutic Radiology and Oncology Consensus Panel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2006.05.015_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0302-2838(02)00505-5","article-title":"PSA progression following radical prostatectomy and radiation therapy: new standards in the new millennium","volume":"43","author":"Djavan","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0094-0143(05)70162-2","article-title":"Salvage radical prostatectomy","volume":"28","author":"Shekarriz","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ejso.2006.05.015_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0360-3016(00)00637-4","article-title":"Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients","volume":"48","author":"Crook","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2006.05.015_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.ju.0000150627.68410.4d","article-title":"Current status of local salvage therapies following radiation failure for prostate cancer","volume":"173","author":"Touma","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0090-4295(99)80054-5","article-title":"Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients","volume":"45","author":"Crook","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.ejso.2006.05.015_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1998.16.1.284","article-title":"Radioimmunoscintigraphy With In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy","volume":"16","author":"Kahn","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2006.05.015_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0022-5347(17)56718-X","article-title":"An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery","volume":"121","author":"Reiner","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000020311","article-title":"Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer","volume":"38","author":"Van Poppel","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00005392-199501000-00037","article-title":"Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels","volume":"153","author":"Rogers","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-5347(01)61790-7","article-title":"Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer","volume":"161","author":"Amling","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0090-4295(98)00096-X","article-title":"Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer","volume":"51","author":"Gheiler","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ejso.2006.05.015_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.urology.2005.04.002","article-title":"Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy","volume":"66","author":"Masterson","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ejso.2006.05.015_bib25","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/01.ju.0000140960.63108.39","article-title":"Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy","volume":"172","author":"Stephenson","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib26","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1200\/JCO.1999.17.8.2514","article-title":"Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy","volume":"17","author":"Pisters","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2006.05.015_bib27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0022-5347(05)66246-5","article-title":"Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications","volume":"165","author":"Chin","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ejso.2006.05.015_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(98)00492-0","article-title":"Salvage brachytherapy for localized prostate cancer after radiotherapy failure","volume":"53","author":"Grado","year":"1999","journal-title":"Urology"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798306002265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798306002265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T20:14:51Z","timestamp":1555704891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798306002265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0748798306002265"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2006.05.015","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}